Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Repisalud
Publicación Artículo científico (JournalArticle)

Polymorphisms within the TNFSF4 and MAPKAPK2 Loci Influence the Risk of Developing Invasive Aspergillosis: A Two-Stage Case Control Study in the Context of the aspBIOmics Consortium

  • Sánchez-Maldonado, Jose Manuel
  • Moñiz-Díez, Ana
  • Ter Horst, Rob
  • Campa, Daniele
  • Cabrera-Serrano, Antonio José
  • Martínez-Bueno, Manuel
  • Garrido-Collado, María Del Pilar
  • Hernández-Mohedo, Francisca
  • Fernández-Puerta, Laura
  • López-Nevot, Miguel Ángel
  • Cunha, Cristina
  • González-Sierra, Pedro Antonio
  • Springer, Jan
  • Lackner, Michaela
  • Alcazar-Fuoli, Laura
  • Fianchi, Luana
  • Aguado, José María
  • Pagano, Livio
  • López-Fernández, Elisa
  • Clavero, Esther
  • Potenza, Leonardo
  • Luppi, Mario
  • Moratalla, Lucia
  • Solano, Carlos
  • Sampedro, Antonio
  • Cuenca-Estrella, Manuel
  • Lass-Flörl, Cornelia
  • PCRAGA Study Group
  • Canzian, Federico
  • Loeffler, Juergen
  • Li, Yang
  • Einsele, Hermann
  • Netea, Mihai G
  • Vázquez, Lourdes
  • Carvalho, Agostinho
  • Jurado, Manuel
  • Sainz, Juan
Here, we assessed whether 36 single nucleotide polymorphisms (SNPs) within the TNFSF4 and MAPKAPK2 loci influence the risk of developing invasive aspergillosis (IA). We conducted a two-stage case control study including 911 high-risk patients diagnosed with hematological malignancies that were ascertained through the aspBIOmics consortium. The meta-analysis of the discovery and replication populations revealed that carriers of the TNFSF4rs7526628T/T genotype had a significantly increased risk of developing IA (p = 0.00022). We also found that carriers of the TNFSF4rs7526628T allele showed decreased serum levels of TNFSF14 protein (p = 0.0027), and that their macrophages had a decreased fungicidal activity (p = 0.048). In addition, we observed that each copy of the MAPKAPK2rs12137965G allele increased the risk of IA by 60% (p = 0.0017), whereas each copy of the MAPKAPK2rs17013271T allele was estimated to decrease the risk of developing the disease (p = 0.0029). Mechanistically, we found that carriers of the risk MAPKAPK2rs12137965G allele showed increased numbers of CD38+IgM-IgD- plasmablasts in blood (p = 0.00086), whereas those harboring two copies of the allele had decreased serum concentrations of thymic stromal lymphopoietin (p = 0.00097). Finally, we also found that carriers of the protective MAPKAPK2rs17013271T allele had decreased numbers of CD27-IgM-IgD- B cells (p = 0.00087) and significantly lower numbers of CD14+ and CD14+CD16- cells (p = 0.00018 and 0.00023). Altogether, these results suggest a role of the TNFSF4 and MAPKAPK2 genes in determining IA risk.